Use of bronchial epithelial cells expressing human cytochrome P450 for study on metabolism and genotoxicity of ochratoxin A

In Vitro and Molecular Toxicology: Journal of Basic and Applied Research

Volumn 10, Issue 1, 1997, Pages 93-102

  Grosse, Y ^a   Monje, M C ^a   Mace K ^b   Pfeifer, A ^b   Pfohl Leszkowicz, A ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; EPOXIDE HYDROLASE; GLUTATHIONE TRANSFERASE; OCHRATOXIN; PROSTAGLANDIN SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

BRONCHUS MUCOSA; CELL LINE; CONFERENCE PAPER; DNA ADDUCT; EPITHELIUM CELL; GENOTOXICITY; HUMAN; HUMAN CELL;

EID: 0031010463     PISSN: 10979336     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. BENDELE, A.M., CARLTON, W.W., KROGH, P., and LILLEHOJ, E.B. (1985). Ochratoxin A carcinogenesis in the (C57BL/6J X C3H)F1 mouse. J. Natl Cancer Inst. 75,733-742.
2. BOORMAN, G., ed. (1989). NTP Technical Report on the Toxicology and Carcinogenesis Studies of OchratoxinA (CAS NO. 303-47-9) in F344/N rats (Gavage studies) (NIH Publication No 89-2813.) US Department of Health and Human Services, National Institutes of Health: Research Triangle Park, NC.
3. CASTEGNARO, M., BARTSCH, H., and CHERNOZEMSKY, I. (1987). Endemic nephropathy and urinary tract tumours in the Balkans. Cancer Res. 47, 3608-3609.
4. CASTEGNARO, M., BARTSCH, H., BÉREZIAT, J.C., ARVELA, P., MICHELON, J., and BROUSSOLE, L. (1989). Polymorphic ochratoxin A hydroxylation in rat strains phenotyped as poor and extensive metabolizers of debrisoquine. Xenobiotica 19, 225-230.
5. CEOVIC, S., HRABAR, A., and SARIC, M. (1992). Epidemiology of Balkan endemic nephropathy. Food Chem. Toxicol. 30, 183-188.
6. CULLIN, C., and POMPON, D. (1988). Synthesis of functional mouse cytochromes P-450 P1 and chimeric P-450 P3-1 in the yeast Saccharomyces cerevisiae. Gene 65, 203-217.
7. GROENE DE E.M., HASSING, G.I.A., BLOM, M.J., SEINEN, W., FINK-GREMMELS, J., and HORBACH, G.J.M.J. (1996). Development of human cytochrome P450-expressing cell lines; application in mutagenicity testing of ochratoxin A. Cancer Res. 56, 299-304.
8. GROSSE, Y., PFOHL-LESZKOWICZ, A., BETBEDER, A.M., CREPPY, E.E., and DIRHEIMER, G. (1995a). Formation of ochratoxin A metabolites and DNA-adducts in monkey kidney cells. Chem. Biol. Interaction, 95, 175-187.
9. GROSSE, Y., CASTEGNARO, M., MACE, K., BARTSCH, H., DIRHEIRMER, G., PINELLI, E., PFEIFER, A., and PFOHL-LESZKOWICZ, A. (1995b). Evaluation of ochratoxin A genotoxicity by DNA-adducts detection: Cytochromes P450 implicated. Clin. Chem. 12, 1927-1929.
10. GROSSE, Y., MACE, K., PFEIFER, A., MEILLER, B., and PFOHL-LESZKOWICZ, A. (1995c). Metabolism and genotoxicity of ochratoxin A: Use of human bronchial epithelial immortalized cells expressing cytochrome P450s. Cell Biol. Toxicol. 11, 196 (abstract).
11. HENNIG, A., FINK-GREMMELS, J., and LEISTNER, L. (1991). Mutagenicity and effects of ochratoxin A on the frequency of sister chromatid exchange after metabolic activation, in: Mycotoxin, Endemic Nephropathy and Urinary Tract Tumors. M. Castegnaro, R. Plestina, G.Dirheimer, I.V. Chernozemsky, and H. Bartsch, (eds.) IARC Scientific publications No 115. International Agency for Research on Cancer: Lyon, pp. 255-260.
12. HIETANEN, E., MALAVEILLE, C., CAMUS, A.-M., BEREZIAT, J.-C., BRUN, G., CASTEGNARO, M., MICHELON, J., IDLE, J.R., and BARTSCH, H. (1986). Interstrain comparison of hepatic and renal microsomal carcinogen metabolism and liver S9-mediated mutagenicity in DA and Lewis rats phenotyped as poor and extensive metabolizers of debrisoquine. Drugs Metabol. Dispos. 14, 118-126.
13. KANIZAWA, M., and SUZUKI, S. (1978). Induction of renal and hepatic tumors in mice by ochratoxin A, a mycotoxin. Gann 69, 599-600.
14. KROGH, P. (1992). Role of ochratoxin in disease causation. Food Chem. Toxicol. 30, 213-224.
15. MACÉ, K., GONZALEZ, F.J., MCCONNEL, I.R., GARNER, R.C., AVANTI, O., HARRIS, C.C., and PFEIFER, A.M.A. (1994). Activation of promutagens in a human bronchial epithelial cell line stably expressing human CYP1A2. Mol. Carcinogen. 11, 65-73.
16. MACÉ, K., VAUTRAVERS, P., GRANATO, D., GONZALEZ, F.J., HARRIS, C.C., and PFEIFER, A. (1997). Development of CYP450-expressing human bronchial epithelial cell lines for in vitro pharmacotoxicological applications. In Vitro Toxicol., this issue.
17. MALAVEILLE, C., BRUN, G., and BARTSCH, H. (1991). Genotoxicity of ochratoxin A and structurally related compounds in Escherichia coli strains: Studies on their mode of action, in: Mycotoxin, Endemic Nepbropathy and Urinary Tract Tumors. IARC Scientific publications No 115) M. Castegnaro, R. Plestina, G. Dirheimer, I.V. Chernozemsky, and H. Bartsch (eds.) International Agency for Research on Cancer: Lyon, pp. 261-266.
18. MALAVEILLE, C., BRUN, G., and BARTSCH, H. (1994). Structure-activity studies in E. coli strains on ochratoxin A (OTA) and its analogues implicate a genotoxic free radical and a cytotoxic thiol derivative as reactive metabolites. Mutat. Res. 307, 141-147.
19. MANOLOVA, Y., MANOLOV, G., PARVANOVA, L., PETKOVA-BOCHAROVA, T., CASTEGNARO, M., and CHERNOZEMSKY, I.N. (1990). Induction of characteristic chromosomal aberrations, particularly X-trisomy, in cultured human lymphocytes treated by ochratoxin A, a mycotoxin implicated in Balkan endemic nephropathy. Mutat. Res. 231, 143-149.
20. NIKOLOV, I.G., CHERNOZEMSKY, I.N., and IDLE, J.R. (1991). Genetic predisposition to Balkan endemic nephropathy: Ability to hydroxylate debrisoquine as a host risk factor, in: Mycotoxin, Endemic Nephropathy and Urinary Tract Tumors. IARC Scientific publications No 115) M. Castegnaro, R. Plestina, G. Dirheimer, I.N. Chernozemsky, and H. Bartsch (eds.) International Agency for Research on Cancer: Lyon, pp. 289-296.
21. OBRECHT-PFLUMIO, S., GROSSE, Y., PFOHLLESZKOWICZ, A., and DIRHEIMER, G. (1996). Protection by indomethacin and aspirin against genotoxicity of ochratoxin A, particularly in the urinary bladder and kidney. Arch. Toxicol. 70, 244-248.
22. PFOHL-LESZKOWICZ, A., CHAKOR, K., CREPPY, E.E., and DIRHEIMER, G. (1991). DNA-adduct formation in mice treated with ochratoxin A, in: Mycotoxin, Endemic Nephropathy and Urinary Tract Tumors. IARC Scientific publications No 115) M. Castegnaro, R. Plestina, G. Dirheimer, I.V. Chernozemsky, and H. Bartsch (eds.) International Agency for Research on Cancer: Lyon, pp. 245-253.
23. PFOHL-LESZKOWICZ, A., GROSSE, Y., KANE, A., CREPPY, E.E., and DIRHEIMER, G. (1993a). Differential DNA adduct formation and disappearance in three mice tissues after treatment by the mycotoxin, ochratoxin A. Mutat. Res. 289, 265-273.
24. PFOHL-LESZKOWICZ, A., GROSSE, Y., OBRECHT, S., KANE, A., CASTEGNARO, M., CREPPY, E.E., and DIRHEIMER, G. (1993b). Preponderance of DNA adducts in kidney afer ochratoxin A exposure, in: Human Ochratoxicosis and Related Pathologies. E.E. Creppy, M. Castegnaro and G. Dirheimer (eds.) J. Libbey Eurotext: London, colloque INSERM, No 231, 199-207.
25. PFOHL-LESZKOWICZ, A., GROSSE, Y., CASTEGNARO, M., NICOLOV, I.G., CHERNOZEMSKY, I.N., BARTSCH, H., BETBEDER, A.M., CREPPY, E.E., and DIRHEIMER, G. (1993c). Ochratoxin A-related DNA adducts in urinary tract tumours of Bulgarian subjects, in: Postlabelling Methods for Detection of DNA Adducts. D.H. Phillips, M. Castegnaro, and H. Bartsch (eds.) IARC Scientific Publication, Lyon: No 124, pp. 141-148.
26. PFOHL-LESZKOWICZ, A., GROSSE, Y., KANE, A., GHARBI, A., BAUDRIMONT, I., OBRECHT, S., CREPPY, E.E., and DIRHEIMER, G. (1993d). Is the oxidative pathway implicated in OTA genotoxicity? in: Human Ochratoxicosis and Its Related Pathologies. E.E. Creppy, M. Castegnaro and G. Dirheimer (eds.) J. Libbey Eurotext: London, colloque INSERM, No 231, pp. 177-188.
27. PFOHL-LESZKOWICZ, A. (1994). L'ochratoxine A, mycotoxine ubiquitaire contaminant l'alimentation humaine. C.R. Soc. Biol. 188, 335-353.
28. PFOHL-LESZKOWICZ, A., OBRECHT, S., GROSSE, Y., and DIRHEIMER, G. (1994). Involvement of antioxidants and inhibitors of glutathione conjugation in ochratoxin A genotoxicity in mice liver and kidney. Toxicol. Lett. 74, 64 [abstract].
29. PFOHL-LESZKOWICZ, A., GROSSE, Y., CARRIÈRE, V., CUGNENC, P.H., BERGER, A., CARNOT, F., BEAUNE, P., and DE WAZIERS, I. (1995). High levels of DNA adducts in Human colon are associated with colorectal cancer. Cancer Res. 55, 5611-5616.
30. PINELLI, E., GROSSE, Y., MEILLER, B., PIPY, B., and PFOHL-LESZKOWICZ, A. (1995). Effect of ochratoxin A on arachidonic pathway: Use of epithelial bronchial cells. Cell Biol. Toxicol. 11, 211 (abstract).
31. REDDEL, R.R., KE, Y., GERWIN, B.I., MCMENAMIN, M.G., LECHNER, J.F., SU, R.T., BRASH, D.E., PARK, J.B., RHIM, J.S., and HARRIS, C.C. (1988). Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes. Cancer Res. 48, 1904-1909.
32. 32P-postlabeling test for structurally diverse DNA-adducts. Carcinogenesis 7, 1543-1551.
33. RENAUD, J.P., CULLIN, C., POMPON, D., BEAUNE, P., and MANSUY, D. (1990). Expression of human liver cytochrome P450 IIIA4 in yeast. Eur. J. Biochem. 194, 889-896.
34. SPEIJERS, G.J.A., and VAN EGMOND, H.P. (1993). Worldwide ochratoxin A levels in food and feeds, in: Human Ochratoxicosis and Its Related Pathologies. E.E. Creppy, M. Castegnaro, and G. Dirheimer (eds.) J. Libbey Eurotext: London, colloque IN-SERM, No 231, pp. 85-100.
35. STØRMER, F.C. (1992). Ochratoxin A. A mycotoxin of concern, in: Handbook of Applied Mycology D. Bhatnagar, E.B. Lillehoj, and D.K. Arora (eds). Marcel Dekker: New York, pp. 403-432.
36. UENO, Y. (1985). Biotransformation of mycotoxins in the reconstituted cytochrome P450 system. Proc. Jpn. Assoc. Mycotox. 22, 28-30.
37. WÜRGLER, F.E., FRIEDERICH, U., and SCHLATTER, J. (1991). Lack of mutagenicity of ochratoxin A and B, citrinine, patulin and cnestine in Salmonella typhimurium TA 102. Mutat. Res. 261, 209-216.
38. ZIMMERLI, B., and DICK, R. (1995). Determination of OTA at the ppt level in human blood, serum, milk, and some foodstuffs by high-performance liquid chromatography with enhanced fluorescence detection and immunoaffinity column cleanup: Methodology and Swiss data. J. Chromatogr. 666, 85-99.